Jade Biosciences (JBIO) Balance Sheet: Assets & Liabilities

Jade Biosciences (JBIO) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), Jade Biosciences reported total assets of $349.78M and total liabilities of $17.26M. Shareholders' equity was $332.52M, up 335.0% from $76.43M a year earlier. Total debt stood at $724.00K against $336.16M in cash and short-term investments, a net cash position of $335.43M. That puts debt-to-equity at 0.00, compared with 0.01 a year earlier.

Jade Biosciences Balance Sheet Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Jade Biosciences, Inc. (JBIO) - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period ending	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Current Assets
Cash and Cash Equivalents	88.44	33.75	23.49	22.40	54.20	4.57	3.51
Short-Term Investments	247.72	44.87	98.95	106.82	113.18	0.00	0.00
Cash & Short-Term Investments	336.16	78.62	122.44	129.22	167.38	4.57	3.51
Accounts Receivable	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Current Assets	12.66	1.49	1.79	2.28	6.96	0.10	0.00
Total Current Assets	348.82	80.12	124.23	131.50	174.33	4.68	3.51
Non-Current Assets
Property, Plant & Equipment (Net)	0.90	0.22	0.90	1.25	0.73	0.04	0.00
Other Non-Current Assets	0.07	0.00	2.28	2.56	0.30	0.00	0.00
Total Non-Current Assets	0.97	0.21	3.19	3.80	1.03	0.04	0.00
Total Assets	349.78	80.33	127.42	135.30	175.36	4.72	3.51
Current Liabilities
Accounts Payable	2.15	0.22	2.40	2.58	1.21	0.62	0.54
Short-Term Debt	0.00	0.42	0.42	0.39	0.19	0.00	0.00
Accrued Liabilities	11.07	9.63	14.82	4.82	1.15	-	-
Other Current Liabilities	14.39	3.19	14.82	4.82	1.15	1.16	0.12
Total Current Liabilities	16.54	3.83	17.64	7.78	2.55	1.77	0.66
Non-Current Liabilities
Long-Term Debt	0.72	0.00	0.26	0.71	0.38	0.00	2.50
Other Non-Current Liabilities	0.00	0.07	0.07	0.07	0.01	0.00	4.00
Total Non-Current Liabilities	0.72	0.07	0.32	0.78	0.40	0.00	6.50
Total Liabilities	17.26	3.90	17.96	8.56	2.95	1.77	7.16
Stockholders' Equity
Common Stock	0.01	0.00	0.00	0.00	0.00	0.00	0.00
Retained Earnings	-174.39	-233.05	-163.42	-87.90	-36.39	-13.41	-3.64
Accumulated Other Comprehensive Income	0.13	0.11	0.24	-0.47	-0.06	0.00	0.00
Additional Paid-in Capital	506.77	309.38	272.64	215.11	208.87	0.06	-4.00
Shares Outstanding	49.32	32.24	-	-	-	-	-
Total Stockholders' Equity	332.52	76.43	109.46	126.74	172.42	2.94	-3.64
Total Liabilities & Equity	349.78	80.33	127.42	135.30	175.36	4.72	3.51

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Jade Biosciences Balance Sheet

How much debt does Jade Biosciences have?

Jade Biosciences had total debt of $724.00K as of Dec 31, 2025, against $336.16M in cash and short-term investments. Its debt-to-equity ratio was 0.00. Total debt was $417.00K a year earlier.

What are Jade Biosciences's total assets?

Jade Biosciences reported total assets of $349.78M as of Dec 31, 2025, up 335.4% from $80.33M a year earlier. Total liabilities were $17.26M.

What is Jade Biosciences's shareholders' equity?

Jade Biosciences's shareholders' equity was $332.52M as of Dec 31, 2025, or about $6.74 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition